Ethical Human Psychology and Psychiatry Volume 7, Number 2, Summer 2005 pp. 111-124 Screening for Mental Illness: The Merger of Eugenics and the Drug Industry Vera Hassner Sharav, MLS New York, NY The implementation by the President’s New Freedom Commission (NFC) to . . . Continue reading →
Not Beneficial
Polypharm & New Antipsychotics Not More Beneficial-Just More Expensive
"modern pharmacological treatment may be no more beneficial than older ones, despite their added cost." Continue reading →
FDA’s Waiting Game Exposes Children to Preventable Risks – 9/04 AHRP Comments to FDA
FDA’s Waiting Game Exposes Children to Preventable Risks Comments by Vera Hassner Sharav President The Alliance for Human Research Protection Submitted to FDA Advisory Committee Psychopharmacological Drugs Advisory Committee and Pediatric Subcommittee Drugs Advisory Committee September 13-14, 2004 Meeting RE: Suicidality Associated . . . Continue reading →
ACNP and SSRI Antidepressants/ Suicidal Behavior
ACNP – a pharmaceutical industry funded association of psychiatrists – claims SSRI Antidepressants don’t increase suicidal behavior Wed, 21 Jan 2004 related links: Reply to ACNP Report – Jonathan Leo, Ph.D. FDA Sham Conflicts of Interest Policy The American College of Neuropsychopharmacologists . . . Continue reading →